Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steffen Pfeuffer

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Frontiers in Neurology|February 2, 2018
Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis-A Longitudinal Observational StudyEster Riepl, Steffen Pfeuffer, Tobias Ruck, et al.
Neurological Research and Practice|June 3, 2026
The use of cladribine tablets in patients with MS beyond the age of 50: experiences from a large tertiary German centreFranziska Axhausen, Stephanie Wolff, Romy Baumgart, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 14, 2020
Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015-2020Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
Drugs|June 4, 2021
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020Niklas Huntemann, Leoni Rolfes, Marc Pawlitzki, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 21, 2020
Autoimmunity complicating SARS-CoV-2 infection in selective IgA-deficiencySteffen Pfeuffer, Matthias Pawlowski, Gunther S Joos, et al.
Therapeutic Advances in Neurological Disorders|March 22, 2021
Teriflunomide treatment is associated with optic nerve recovery in early multiple sclerosisSteffen Pfeuffer, Laura Kerschke, Tobias Ruck, et al.
European Journal of Neurology|November 24, 2020
Patients with a relapsing course of steroid-responsive encephalopathy associated with autoimmune thyroiditis exhibit persistent intrathecal CD4+ T-cell activationSteffen Pfeuffer, Tobias Ruck, Leoni Rolfes, et al.
Neurological Research and Practice|November 14, 2025
Acute myeloneuropathy after nitrous oxide use: multimodal diagnostic insights : Response to research article: increase of nitrous oxide-induced neurological disorders - a German multicenter experience by Meißner et alJulius Runzheimer, Omar Alhaj Omar, Martin Jünemann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 15, 2024
Ofatumumab-induced severe reactivation of psoriasis in a patient with multiple sclerosisTristan Kölsche, Alice Grizzel Willison, Sven G Meuth, et al.
Journal of Neurology|February 15, 2020
MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentationJulia Loos, Steffen Pfeuffer, Katrin Pape, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Frontiers in Neurology|February 2, 2018
Alemtuzumab Improves Cognitive Processing Speed in Active Multiple Sclerosis-A Longitudinal Observational StudyEster Riepl, Steffen Pfeuffer, Tobias Ruck, et al.
Neurological Research and Practice|June 3, 2026
The use of cladribine tablets in patients with MS beyond the age of 50: experiences from a large tertiary German centreFranziska Axhausen, Stephanie Wolff, Romy Baumgart, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 14, 2020
Failed, Interrupted, or Inconclusive Trials on Immunomodulatory Treatment Strategies in Multiple Sclerosis: Update 2015-2020Leoni Rolfes, Marc Pawlitzki, Steffen Pfeuffer, et al.
Drugs|June 4, 2021
Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020Niklas Huntemann, Leoni Rolfes, Marc Pawlitzki, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|August 21, 2020
Autoimmunity complicating SARS-CoV-2 infection in selective IgA-deficiencySteffen Pfeuffer, Matthias Pawlowski, Gunther S Joos, et al.
Therapeutic Advances in Neurological Disorders|March 22, 2021
Teriflunomide treatment is associated with optic nerve recovery in early multiple sclerosisSteffen Pfeuffer, Laura Kerschke, Tobias Ruck, et al.
European Journal of Neurology|November 24, 2020
Patients with a relapsing course of steroid-responsive encephalopathy associated with autoimmune thyroiditis exhibit persistent intrathecal CD4+ T-cell activationSteffen Pfeuffer, Tobias Ruck, Leoni Rolfes, et al.
Neurological Research and Practice|November 14, 2025
Acute myeloneuropathy after nitrous oxide use: multimodal diagnostic insights : Response to research article: increase of nitrous oxide-induced neurological disorders - a German multicenter experience by Meißner et alJulius Runzheimer, Omar Alhaj Omar, Martin Jünemann, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 15, 2024
Ofatumumab-induced severe reactivation of psoriasis in a patient with multiple sclerosisTristan Kölsche, Alice Grizzel Willison, Sven G Meuth, et al.
Journal of Neurology|February 15, 2020
MOG encephalomyelitis: distinct clinical, MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentationJulia Loos, Steffen Pfeuffer, Katrin Pape, et al.
Pageof 7